Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kruppel-like factor 2 pseudogene 2 (KLF2P2) is a human genomic locus classified as a pseudogene; it is not known to code for a functional protein. It is related by sequence similarity to Kruppel-like factor 2 (KLF2), a zinc finger transcription factor involved in diverse cellular functions, but does not itself encode a functional transcription factor and has no demonstrated biological activity or disease association[1]. Thus, it is not considered a therapeutic target or receptor. KLF2P2 is specifically classified as a pseudogene and not a protein-coding gene[1]. Pseudogenes like KLF2P2 generally lack biological function and do not serve as drug targets or disease biomarkers. The canonical function, molecular activity, and disease involvement of actual KLF family members (e.g., KLF2) cannot be ascribed to KLF2P2, which is non-coding and lacks evidence for transcriptional or protein-coding activity in the literature or major gene/protein databases[1]. KLF2 (Kruppel-like factor 2) is a well-characterized transcription factor and considered a therapeutic target in some research contexts due to roles in cellular regulation and disease[4][5][7]. KLF2P2 is only a sequence-related pseudogene, without functions or clinical relevance established in scientific sources. KLF2P2 is a pseudogene, not an active target or biologically relevant molecule, and is not associated with drugs, biomarkers, or therapeutic mechanisms[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kruppel-like factor 2 pseudogene 2 (KLF2P2).